Assessment of the Interventional Neuroradiology Workforce in the United States: A Review of the Existing Data

References

1. ↵
   Higashida RT, Hopkins LN, Berenstein A, Halbach VV, Kerber C. Program requirements for residency/fellowship education in neuroendovascular surgery/interventional neuroradiology: a special report on graduate medical education. AJNR Am J Neuroradiol 2000;21:1153–1159

   Abstract/FREE Full Text
2. ↵
   Canto JG, Every NR, Magid DJ, et al. The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators. N Engl J Med 2000;342:1573–1580

   CrossRefPubMedWeb of Science
3. ↵
   Edwards EB, Roberts JP, McBride MA, Schulak JA, Hunsicker LG. The effect of the volume of procedures at transplantation centers on mortality after liver transplantation. N Engl J Med 1999;341:2049–2053

   CrossRefPubMedWeb of Science
4. ↵
   Graduate Medical Education Advisory Committee. Report to the Graduate Medical Education Advisory Committee: summary report. In: Services. Washington: U.S. Department of Health and Human Services;1981
5. ↵
   Council on Graduate Medical Education. Improving access to health care through physician workforce reform: directions for the 21st century: 3rd report to Congress and the Health and Human Services Secretary. Rockville: Health and Human Services Administration;1992
6. ↵
   Ullyot DJ. President’s page: work force issues in cardiology. J Am Coll Cardiol 1995;25:278–279

   CrossRefPubMedWeb of Science
7. Goldstein S, Alpert JS. The cardiovascular work force: too large for the future? Am J Cardiol 1994;74:394–395

   CrossRefPubMedWeb of Science
8. Conti CR. Are there too many cardiologists? A cardiologist’s opinion. Clin Cardiol 1995;18:119–121

   PubMed
9. Moore FI, Brundage BH, Adolph RJ, et al. Data bases and methods for adult cardiology manpower analysis-a critical review. J Am Coll Cardiol 1988;12:836–840

   PubMed
10. ↵
    Beller GA, Vogel RA. Are we training too many cardiologists? Circulation 1997;96:372–378
11. ↵
    Covey AM, Sunshine J, Forman HP. The job market in diagnostic radiology 1999: updated findings from a help wanted index of job advertisements. AJR Am J Roentgenol 2000;175:957–961

    PubMed
12. ↵
    Covey AM, Sunshine J, Forman HP. Changes in the job market for interventional radiology as detected through a help-wanted index of job advertisements. Acad Radiol 2001;8:175–181

    PubMed
13. ↵
    Goodman DC, Fisher ES, Bubolz TA, Mohr JE, Poage JF, Wennberg JE. Benchmarking the US physician workforce. An alternative to needs-based or demand-based planning. JAMA 1996;276:1811–1817

    CrossRefPubMedWeb of Science
14. ↵
    Skolnick BE. Guidelines for acute stroke treatment centers. Phys Med Rehabil Clin N Am 1999;10:801–813

    PubMed
15. ↵
    Emergency brain resuscitation: a working group on emergency brain resuscitation. Ann Intern Med 1995;122:622–627

    PubMedWeb of Science
16. ↵
    Allder SJ, Moody AR, Martel AL, et al. Limitations of clinical diagnosis in acute stroke. Lancet 1999;354:1523

    CrossRefPubMedWeb of Science
17. Sunshine JL, Tarr RW, Lanzieri CF, Landis DM, Selman WR, Lewin JS. Hyperacute stroke: ultrafast MR imaging to triage patients prior to therapy. Radiology 1999;212:325–332

    PubMedWeb of Science
18. ↵
    Suarez JI, Sunshine JL, Tarr R, et al. Predictors of clinical improvement, angiographic recanalization, and intracranial hemorrhage after intra-arterial thrombolysis for acute ischemic stroke. Stroke 1999;30:2094–2100

    Abstract/FREE Full Text
19. ↵
    Albers GW. Expanding the window for thrombolytic therapy in acute stroke: the potential role of acute MRI for patient selection. Stroke 1999;30:2230–2237

    Abstract/FREE Full Text
20. ↵
    Hospital and prehospital resources for optimal care of the injured patient: Committee on Trauma of the American College of Surgeons. Bull Am Coll Surg 1986;71:4–23
21. ↵
    Menghini VV, Brown RD Jr, Sicks JD, O’Fallon WM, Wiebers DO. Incidence and prevalence of intracranial aneurysms and hemorrhage in Olmsted County, Minnesota, 1965 to 1995. Neurology 1998;51:405–411

    Abstract/FREE Full Text
22. ↵
    Sacchetti ML, Toni D, Fiorelli M, Argentino C, Fieschi C. The concept of combination therapy in acute ischemic stroke. Neurology 1997;49:S70–S74

    FREE Full Text
23. ↵
    Antman EM, Giugliano RP, Gibson CM, et al. Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators. Circulation 1999;99:2720–2732

    Abstract/FREE Full Text
24. ↵
    Ohman EM, Kleiman NS, Gacioch G, et al. Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo- controlled, dose-ranging trial. IMPACT-AMI Investigators. Circulation 1997;95:846–854

    Abstract/FREE Full Text
25. ↵
    Opatowsky MJ, Morris PP, Regan JD, Mewborne JD, Wilson JA. Rapid thrombectomy of superior sagittal sinus and transverse sinus thrombosis with a rheolytic catheter device. AJNR Am J Neuroradiol 1999;20:414–417

    Abstract/FREE Full Text
26. ↵
    Dowd CF, Malek AM, Phatouros CC, Hemphill JC III. Application of a rheolytic thrombectomy device in the treatment of dural sinus thrombosis: a new technique. AJNR Am J Neuroradiol 1999;20:568–570

    Abstract/FREE Full Text
27. ↵
    Ueda T, Hatakeyama T, Kohno K, Kumon Y, Sakaki S. Endovascular treatment for acute thrombotic occlusion of the middle cerebral artery: local intra-arterial thrombolysis combined with percutaneous transluminal angioplasty. Neuroradiology 1997;39:99–104

    CrossRefPubMed
28. Ueda T, Sakaki S, Nochide I, Kumon Y, Kohno K, Ohta S. Angioplasty after intra-arterial thrombolysis for acute occlusion of intracranial arteries. Stroke 1998;29:2568–2574

    Abstract/FREE Full Text
29. ↵
    Nakayama T, Tanaka K, Kaneko M, Yokoyama T, Uemura K. Thrombolysis and angioplasty for acute occlusion of intracranial vertebrobasilar arteries: report of three cases. J Neurosurg 1998;88:919–922

    PubMedWeb of Science
30. ↵
    Barnwell SL, Clark WM, Nguyen TT, O’Neill OR, Wynn ML, Coull BM. Safety and efficacy of delayed intraarterial urokinase therapy with mechanical clot disruption for thromboembolic stroke. AJNR Am J Neuroradiol 1994;15:1817–1822

    Abstract/FREE Full Text
31. Jahan R, Duckwiler GR, Kidwell CS, et al. Intraarterial thrombolysis for treatment of acute stroke: experience in 26 patients with long-term follow-up. AJNR Am J Neuroradiol 1999;20:1291–1299

    Abstract/FREE Full Text
32. ↵
    Hill MD, Barber PA, Demchuk AM, et al. Acute intravenous intra-arterial revascularization therapy for severe ischemic stroke. Stroke 2002;33:279–282

    Abstract/FREE Full Text
33. ↵
    Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003–2011

    CrossRefPubMedWeb of Science
34. del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke 1998;29:4–11

    Abstract/FREE Full Text
35. ↵
    Lewandowski CA, Frankel M, Tomsick TA, et al. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999;30:2598–2605

    Abstract/FREE Full Text
36. ↵
    Lacy CR, Suh DC, Bueno M, Kostis JB. Delay in presentation and evaluation for acute stroke: Stroke Time Registry for Outcomes Knowledge and Epidemiology (S.T.R.O.K.E.). Stroke 2001;32:63–69

    Abstract/FREE Full Text
37. ↵
    Morgenstern LB, Staub L, Chan W, et al. Improving Delivery of Acute Stroke Therapy: The TLL Temple Foundation Stroke Project. Stroke 2002;33:160–166

    Abstract/FREE Full Text
38. ↵
    Riopelle RJ, Howse DC, Bolton C, et al. Regional access to acute ischemic stroke intervention. Stroke 2001;32:652–655

    Abstract/FREE Full Text
39. ↵
    Williams GR, Jiang JG, Matchar DB, Samsa GP. Incidence and occurrence of total (first-ever and recurrent) stroke. Stroke 1999;30:2523–2528

    Abstract/FREE Full Text
40. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 1999;282:2019–2026

    CrossRefPubMedWeb of Science
41. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581–1587

    CrossRefPubMedWeb of Science
42. Chiu D, Krieger D, Villar-Cordova C, et al. Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice. Stroke 1998;29:18–22

    Abstract/FREE Full Text
43. Zweifler RM, Brody ML, Graves GC, et al. Intravenous t-PA for acute ischemic stroke: therapeutic yield of a stroke code system. Neurology 1998;50:501–503

    Abstract/FREE Full Text